Literature DB >> 20734217

Clinical and microbiological characteristics of Klebsiella pneumoniae isolates causing community-acquired urinary tract infections.

W-H Lin1, M-C Wang, C-C Tseng, W-C Ko, A-B Wu, P-X Zheng, J-J Wu.   

Abstract

BACKGROUND: Klebsiella pneumoniae is the second most common species causing urinary tract infections (UTI). However, the host factors and virulence genes of K. pneumoniae related to UTI are poorly understood. The aim of this study was to analyze the capsular phenotype and virulence genes of K. pneumoniae isolates and host factors potentially relevant to community-acquired UTI.
METHODS: Fifty-four K. pneumoniae isolates from patients with community-acquired UTI, 76 isolates from healthy adults, and 29 from patients with community-acquired pneumonia were compared. The virulence genes (rmpA, magA, uge, and wabG) and serotype (K1, K2, K5, K20, K54, or K57) were characterized by polymerase chain reaction (PCR). The modified string test was used to determine the hypermucoviscosity.
RESULTS: Diabetes mellitus was the most frequent underlying disease among UTI patients (53.7%, 29/54). No predominant K serotype was found in UTI strains. The hypermucoviscosity phenotype and rmpA gene were more often found in UTI isolates than in those from healthy adults (27.8 vs. 2.6%, P < 0.01; 29.6 vs. 11.8%, P < 0.01, respectively), whereas no significant difference in the frequency of magA, uge, wabG, or serotype genes was found. The prevalence of rmpA was significantly lower in isolates from patients with immunosuppression, chronic renal insufficiency, and urinary tract obstruction. Multivariate analysis showed that immunosuppression was negatively associated with the prevalence of rmpA.
CONCLUSION: Hypermucoviscosity was highly correlated with the presence of the rmpA gene in UTI strains, and rmpA may have a role in community-acquired UTI, especially in hosts without immunosuppression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20734217     DOI: 10.1007/s15010-010-0049-5

Source DB:  PubMed          Journal:  Infection        ISSN: 0300-8126            Impact factor:   3.553


  32 in total

1.  Investigation of the putative virulence gene magA in a worldwide collection of 495 Klebsiella isolates: magA is restricted to the gene cluster of Klebsiella pneumoniae capsule serotype K1.

Authors:  Carsten Struve; Martin Bojer; Eva Møller Nielsen; Dennis Schrøder Hansen; Karen A Krogfelt
Journal:  J Med Microbiol       Date:  2005-11       Impact factor: 2.472

2.  Identification and characterization of the genes encoding the type 3 and type 1 fimbrial adhesins of Klebsiella pneumoniae.

Authors:  G F Gerlach; S Clegg; B L Allen
Journal:  J Bacteriol       Date:  1989-03       Impact factor: 3.490

3.  Capsular serotype K1 or K2, rather than magA and rmpA, is a major virulence determinant for Klebsiella pneumoniae liver abscess in Singapore and Taiwan.

Authors:  Kuo-Ming Yeh; A Kurup; L K Siu; Y L Koh; Chang-Phone Fung; Jung-Chung Lin; Te-Li Chen; Feng-Yee Chang; Tse-Hsien Koh
Journal:  J Clin Microbiol       Date:  2006-12-06       Impact factor: 5.948

4.  PapG II adhesin in the establishment and persistence of Escherichia coli infection in mouse kidneys.

Authors:  C C Tseng; J J Huang; M C Wang; A B Wu; W C Ko; W C Chen; J J Wu
Journal:  Kidney Int       Date:  2007-02-07       Impact factor: 10.612

5.  Virulence characteristics of Escherichia coli causing first urinary tract infection predict risk of second infection.

Authors:  B Foxman; L Zhang; P Tallman; K Palin; C Rode; C Bloch; B Gillespie; C F Marrs
Journal:  J Infect Dis       Date:  1995-12       Impact factor: 5.226

6.  Clinical spectrum and molecular characteristics of Klebsiella pneumoniae causing community-acquired extrahepatic abscess.

Authors:  Yee-Huang Ku; Yin-Ching Chuang; Wen-Liang Yu
Journal:  J Microbiol Immunol Infect       Date:  2008-08       Impact factor: 4.399

7.  The role of K antigens as virulence factors in Klebsiella.

Authors:  A M Simoons-Smit; A M Verweij-van Vught; D M MacLaren
Journal:  J Med Microbiol       Date:  1986-03       Impact factor: 2.472

8.  Mucoid phenotype of Klebsiella pneumoniae is a plasmid-encoded virulence factor.

Authors:  X Nassif; J M Fournier; J Arondel; P J Sansonetti
Journal:  Infect Immun       Date:  1989-02       Impact factor: 3.441

9.  Virulence characteristics of Klebsiella and clinical manifestations of K. pneumoniae bloodstream infections.

Authors:  Victor L Yu; Dennis S Hansen; Wen Chien Ko; Asia Sagnimeni; Keith P Klugman; Anne von Gottberg; Herman Goossens; Marilyn M Wagener; Vicente J Benedi
Journal:  Emerg Infect Dis       Date:  2007-07       Impact factor: 6.883

10.  Community-acquired Klebsiella pneumoniae bacteremia: global differences in clinical patterns.

Authors:  Wen-Chien Ko; David L Paterson; Anthanasia J Sagnimeni; Dennis S Hansen; Anne Von Gottberg; Sunita Mohapatra; Jose Maria Casellas; Herman Goossens; Lutfiye Mulazimoglu; Gordon Trenholme; Keith P Klugman; Joseph G McCormack; Victor L Yu
Journal:  Emerg Infect Dis       Date:  2002-02       Impact factor: 6.883

View more
  19 in total

1.  Capsular serotypes and multilocus sequence types of bacteremic Klebsiella pneumoniae isolates associated with different types of infections.

Authors:  C H Liao; Y T Huang; C Y Chang; H S Hsu; P R Hsueh
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-09-09       Impact factor: 3.267

2.  Clinical and microbiological characteristics of Klebsiella pneumoniae from community-acquired recurrent urinary tract infections.

Authors:  W H Lin; C Y Kao; D C Yang; C C Tseng; A B Wu; C H Teng; M C Wang; J J Wu
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-04-23       Impact factor: 3.267

3.  Characterization of Hypervirulent Extended-Spectrum β-Lactamase-Producing Klebsiella pneumoniae Among Urinary Tract Infections: The First Report from Iran.

Authors:  Azadeh Taraghian; Bahram Nasr Esfahani; Sharareh Moghim; Hossein Fazeli
Journal:  Infect Drug Resist       Date:  2020-09-09       Impact factor: 4.003

4.  Characterization of Klebsiella pneumoniae isolated from patients suspected of pulmonary or bubonic plague during the Madagascar epidemic in 2017.

Authors:  Minoarisoa Rajerison; Jean-Marc Collard; Andriniaina Rakotondrasoa; Lova Maminirina Andrianonimiadana; Soloandry Rahajandraibe; Solohery Razafimahatratra; Voahangy Andrianaivoarimanana; Soanandrasana Rahelinirina; Tania Crucitti; Sylvain Brisse; Victor Jeannoda
Journal:  Sci Rep       Date:  2022-04-27       Impact factor: 4.996

5.  A Case of Ventriculitis Associated with Renal Abscess Caused by Serotype K1 Klebsiella pneumoniae.

Authors:  Ji In Hyun; Youn Jeong Kim; Yoon Hee Jeon; Sang Il Kim; Yeon Joon Park; Moon Won Kang; Woohyeon Kim; Ji Hye Jang
Journal:  Infect Chemother       Date:  2014-06-20

6.  Prevalence assessment of magA gene and antimicrobial susceptibility of Klebsiella pneumoniae isolated from clinical specimens in Shahrekord, Iran.

Authors:  Hadis Amraie; Pegah Shakib; Samaneh Rouhi; Neda Bakhshandeh; Behnam Zamanzad
Journal:  Iran J Microbiol       Date:  2014-10

7.  Metabolic response to Klebsiella pneumoniae infection in an experimental rat model.

Authors:  Fangcong Dong; Bin Wang; Lulu Zhang; Huiru Tang; Jieshou Li; Yulan Wang
Journal:  PLoS One       Date:  2012-11-30       Impact factor: 3.240

8.  Microbiological and clinical characteristics of bacteraemia caused by the hypermucoviscosity phenotype of Klebsiella pneumoniae in Korea.

Authors:  S W Jung; H J Chae; Y J Park; J K Yu; S Y Kim; H K Lee; J H Lee; J M Kahng; S O Lee; M K Lee; J H Lim; C H Lee; S J Chang; J Y Ahn; J W Lee; Y G Park
Journal:  Epidemiol Infect       Date:  2012-05-14       Impact factor: 4.434

9.  Genetic analysis of capsular polysaccharide synthesis gene clusters in 79 capsular types of Klebsiella spp.

Authors:  Yi-Jiun Pan; Tzu-Lung Lin; Chun-Tang Chen; Yi-Yin Chen; Pei-Fang Hsieh; Chun-Ru Hsu; Meng-Chuan Wu; Jin-Town Wang
Journal:  Sci Rep       Date:  2015-10-23       Impact factor: 4.379

10.  Capsular types of Klebsiella pneumoniae revisited by wzc sequencing.

Authors:  Yi-Jiun Pan; Tzu-Lung Lin; Yen-Hua Chen; Chun-Ru Hsu; Pei-Fang Hsieh; Meng-Chuan Wu; Jin-Town Wang
Journal:  PLoS One       Date:  2013-12-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.